Whats new
Whats new.
Ladenburg Thalmann - One Drug, Multiple Late-stage Opportunities; Reiterate Buy Rating (NASDAQ:IMMP) (Analyst: Dr Ahu Demir)
August 1st 2022
For a copy of this research report please contact your Ladenburg advisor.
Whats new
August 1st 2022
For a copy of this research report please contact your Ladenburg advisor.